Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | +0.87% | +3.74% | -5.82% |
Financials (USD)
Sales 2024 * | 126M | Sales 2025 * | 145M | Capitalization | 178M |
---|---|---|---|---|---|
Net income 2024 * | 6M | Net income 2025 * | 18M | EV / Sales 2024 * | 1.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
26.5
x | P/E ratio 2025 * |
10.1
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.63% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | +0.87% | ||
1 week | +3.74% | ||
Current month | -0.17% | ||
1 month | -9.19% | ||
3 months | -30.18% | ||
6 months | -18.69% | ||
Current year | -5.82% |
Managers | Title | Age | Since |
---|---|---|---|
John Morberg
DFI | Director of Finance/CFO | 60 | 21-01-17 |
Steve Laninga
COO | Chief Operating Officer | - | 19-12-31 |
Matt Augustson
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 18-10-11 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 20-10-13 |
Katrina Houde
BRD | Director/Board Member | 66 | 19-08-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.86% | - | |
0.00% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.84 | +1.04% | 99,300 |
24-05-30 | 5.78 | +1.05% | 162,782 |
24-05-29 | 5.72 | +2.51% | 134,216 |
24-05-28 | 5.58 | -0.71% | 270,303 |
24-05-24 | 5.62 | -1.23% | 110,796 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.82% | 178M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- LFCR Stock